Efficacy of a food supplement in patients with hashimoto thyroiditis

M Nordio, S Basciani

Article ID: 5786
Vol 29, Issue 1, 2015
DOI: https://doi.org/10.54517/jbrha5786
Received: 8 April 2015; Accepted: 8 April 2015; Available online: 8 April 2015; Issue release: 8 April 2015

Abstract

Thyroid inflammation has been commonly seen in recent decades, due to a series of factors and is considered as the most frequent thyroid illness. It is characterized by some distinctive traits, which include morphological and hormonal modifications, often in association with an elevated anti-thyroid autoantibody title. The aim of the therapy is to improve symptoms as fast as possible, treating inflammation and subsequent hypothyroidism, when present. Therefore, we evaluated the efficacy of a Food Supplement (FS) containing enzymes which is commonly used in various inflammatory processes and is able to modulate immune reactions during inflammation in a very rapid and efficacious way. An open, controlled study was then designed and 45 patients with Hashimoto thyroiditis were enrolled and divided into 3 groups (FS alone; thyroid hormones alone; FS plus thyroid hormones). Blood, morphological and subjective parameters were considered. The results obtained indicate that the FS used in our study is efficacious and safe when used alone and/or in combination with thyroid hormones in the treatment of autoimmune thyroiditis, as documented by the improvement of the majority of the parameters considered. The efficacy was considered faster than thyroid hormones alone as far as subjective symptomatology is considered. In conclusion, the use of the food supplement evaluated herein during inflammation may be considered an additional tool in clinicians hands, when facing patients with autoimmune thyroiditis, especially in presence of subjective symptomatology, in order to rapidly alleviate it.


Keywords

thyroid;Hashimoto thyroiditis;therapy;nutraceuticals;hormones


References

Supporting Agencies



Copyright (c) 2015 M Nordio, S Basciani




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).